An Alternative Treatment Option for Congenital Syphilis: A Case Series
Abstract
ABSTRACT
Newborn babies born to untreated syphilis-positive mothers need to be treated adequately and timely to prevent and cure congenital syphilis. Penicillin is one of the most robust and the most recommended drug for the same. However, in case of penicillin shortage or an adverse effect to penicillin, an alternative treatment is warranted. Injection ceftriaxone is a promising drug in case of penicillin unavailability. We present a case series in which we treated five asymptomatic newborn babies having positive venereal disease research laboratory (VDRL) titers with ceftriaxone 100 mg/kg/day in two divided doses for 10 days. The patients were cured and discharged on Day 11.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.